University of California, San Francisco
United States
Sheila M. Keating spends much of her time researching Immunology, Virology, T cell, Vaccination and Plasmodium falciparum. Her Immunology research incorporates themes from Vaccinia and Hematopoietic stem cell transplantation. The concepts of her Hematopoietic stem cell transplantation study are interwoven with issues in Lymph node and Blood plasma.
In her study, Circumsporozoite protein is strongly linked to Immunogenicity, which falls under the umbrella field of Virology. Her Virus research is multidisciplinary, relying on both Innate immune system and Immune system. As a part of the same scientific family, she mostly works in the field of Stem cell, focusing on Peripheral and, on occasion, Viral load.
Her scientific interests lie mostly in Immunology, Virology, Internal medicine, Viral load and Immune system. Inflammation, Vaccination, Cytokine, T cell and Chemokine are subfields of Immunology in which her conducts study. Her study of Virus is a part of Virology.
Her biological study spans a wide range of topics, including Gastroenterology, Endocrinology, Oncology and Cardiology. Her work deals with themes such as Stem cell, Hiv incidence and Transplantation, which intersect with Viral load. Her research in Antibody intersects with topics in HIV Antigens and Antigen.
Her primary scientific interests are in Internal medicine, Immune system, Immunology, T cell and Avidity. Her studies deal with areas such as Antibody, Critically ill, Physiology and Transplantation as well as Immune system. Her Antibody study integrates concerns from other disciplines, such as Clinical trial, Cohort and Virology.
Her Virology research incorporates elements of Clinical microbiology and Antiretroviral therapy. Her Immunology research integrates issues from Effects of sleep deprivation on cognitive performance and Serum albumin. Sheila M. Keating interconnects Incidence and Viral load in the investigation of issues within Avidity.
Gold standard, Statistics, Repeatability, Biomedical engineering and Confidence interval are her primary areas of study. Her work carried out in the field of Statistics brings together such families of science as Incidence, Viral load and Antigen. Her Antigen study typically links adjacent topics like Reproducibility.
Her Reproducibility research includes themes of Concordance, Red blood cell and Avidity. Her Repeatability study combines topics in areas such as Reliability, Percentage point and Accuracy and precision.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
Helen McShane;Ansar A Pathan;Clare R Sander;Sheila M Keating.
Nature Medicine (2004)
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases
Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano.
Annals of Internal Medicine (2014)
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
Daniel P. Webster;Susanna Dunachie;Jenni M. Vuola;Tamara Berthoud.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
Timothy J. Henrich;Timothy J. Henrich;Zixin Hu;Zixin Hu;Jonathan Z. Li;Jonathan Z. Li;Gaia Sciaranghella.
The Journal of Infectious Diseases (2013)
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
Steven A. Yukl;Eli Boritz;Michael Busch;Christopher Bentsen.
PLOS Pathogens (2013)
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.
S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating.
Infection and Immunity (2006)
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.
Vasee S Moorthy;Egeruan B Imoukhuede;Paul Milligan;Kalifa Bojang.
PLOS Medicine (2004)
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
Norman L. Letvin;Srinivas S. Rao;David C. Montefiori;Michael S. Seaman.
Science Translational Medicine (2011)
Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers
Jenni M. Vuola;Sheila Keating;Daniel P. Webster;Tamara Berthoud.
Journal of Immunology (2005)
Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria
Sheila M. Keating;Philip Bejon;Tamara Berthoud;Jenni M. Vuola.
Journal of Immunology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
University of California, San Francisco
University of Oxford
University of Oxford
University of California, San Francisco
University of California, San Francisco
University of Oxford
University of Oxford
University of California, San Francisco
University of California, San Diego
University of California, Santa Barbara
Istanbul Ticaret University
TU Dresden
University of North Carolina at Chapel Hill
Leiden University
Utrecht University
University of Auckland
Harvard University
Duke University
James Hutton Institute
Kyushu University
National Institutes of Health
University of Rochester
University of California, San Diego
University of New South Wales
University of Nottingham